Indications:

• Non-insulin dependent (type-II) diabetes mellitus, whenever blood glucose levels cannot be controlled adequately by diet, physical exercise and weight reduction alone.
• Glip may be combined with other, non-betacytotropic, oral antidiabetics.
• Glip may also be used together with insulin.
• Glip is not suitable for the treatment of insulin dependent (type-1) diabetes mellitus, of diabetic ketoacidosis, or of diabetic precoma or coma.

Following information see from leaflet inside the pack:

Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warinings and precautions, adverse ractions, drug interations, use in special population, overdosage.